RKDA

Arcadia Biosciences, Inc.
CAPPED RATING

Arcadia Biosciences Inc is an agricultural biotechnology trait company. The company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets.

Arcadia Biosciences, Inc. (RKDA) is rated C- (2.0/5) on Deltasharpe Prism, scored against Consumer Defensive sector peers. Its strongest pillar is Value (B); its weakest is Momentum (F). The rating has held at C- for 11 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.0 / 5.0
C-
Value
B
Factor Score 3.3 / 5.0
Growth
C-
Factor Score 2.0 / 5.0
Profitability
C-
Factor Score 1.9 / 5.0
Momentum
F
Factor Score 0.3 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -0.2
EV / EBITDA 1.0
Rev Growth YoY -0.8%
Gross Margin 34.6%
Price Return 3M -54.6%
Price Return 12M -93.9%
Catalyst Signal 0.00
Market Cap $525.2K
TTM Revenue $4.7M
Price / Sales 0.1
ROE -430.9%

Historical Factor Score Progression

Held C- for 11 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 B (3.3) C- (2.0) C- (1.9) F (0.3) C+ (2.6) C- (2.0)
2026-11-07 B (3.3) C- (2.1) C- (2.0) F (0.1) C+ (2.5) C- (2.0)
2026-10-31 B (3.4) C- (2.0) C- (2.0) F (0.2) C (2.5) C- (2.0)
2026-10-24 B (3.4) C- (2.0) C- (2.0) F (0.2) C (2.3) C- (2.0)
2026-10-17 B (3.4) C- (2.0) C- (2.0) F (0.2) C (2.4) C- (2.0)
Page 1 of 3